Ulrich Granzer
Directeur Général chez Granzer Regulatory Consulting & Services
Provenance du réseau au premier degré de Ulrich Granzer
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto.
34
| Private Company | Investment Managers | 34 |
| Public Company | Pharmaceuticals: Major | 27 | |
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria.
8
| Holding Company | Biotechnology | 8 |
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ulrich Granzer via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BIOFRONTERA INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Investor Relations Contact Director/Board Member General Counsel | |
Biofrontera Pharma GmbH
 Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The private company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
AYOXXA Biosystems GmbH
 AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| 2INVEST AG | Financial Conglomerates | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| Ruhr-Universität Bochum | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
EnOcean GmbH
 EnOcean GmbH Electronic Production EquipmentElectronic Technology EnOcean GmbH develops and provides patented self-powered wireless technology. It manufactures and markets maintenance-free wireless sensor solutions for use in buildings and industrial installations. The firm's solutions are based on miniaturized energy converters, ultra-low-power electronic circuitry, and reliable wireless. Its products include accessories, software and firmware. The company was founded by Andreas Schneider and Frank Schmidt in 2001 and is headquartered in Oberhaching, Germany. | Electronic Production Equipment | Director/Board Member Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Basel | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor Private Equity Investor | |
eWise Group, Inc.
 eWise Group, Inc. Packaged SoftwareTechnology Services eWise Group, Inc. provides financial software solutions. It products include money manager, personal data vault, connected insights and resources. The company was founded by Alexander Grinberg in 2000 and is headquartered in Centennial, CO. | Packaged Software | Director/Board Member Director/Board Member | |
| Technische Universität München | College/University | Doctorate Degree Doctorate Degree | |
| Wellington Partners Advisory AG | Corporate Officer/Principal Director of Finance/CFO | ||
| 4BASEBIO PLC | Biotechnology | Director/Board Member Chief Executive Officer | |
| ABLYNX | Biotechnology | Chairman Chairman | |
| University of California, Berkeley | College/University | Graduate Degree Masters Business Admin | |
| EPIGENOMICS AG | Medical Specialties | Director/Board Member Chairman | |
Biofrontera Bioscience GmbH
 Biofrontera Bioscience GmbH Financial ConglomeratesFinance Part of Biofrontera AG, Biofrontera Bioscience GmbH is a German commercial biotech company that provides high-quality treatment options in photodynamic therapy and topical antibiotics. The private company is based in Leverkusen, Germany. The CEOs of the company are Thomas Schaffer, Hermann Lübbert. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
| Universität zu Köln | College/University | Doctorate Degree Doctorate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Technical University of Berlin | College/University | Graduate Degree Doctorate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GLO AB
 GLO AB SemiconductorsElectronic Technology GLO AB operates as a holding company. It develops technologies to fabricate defect-free, single-crystal semiconductor nanowire structures, with direct control of morphology and chemical composition. The firm focuses on the development and commercialization of light-emitting diode products using nanotechnology. Its products can be use in display, automotive and illumination application. The company was founded by Lars Ivar Samuelson, Steven Alan Morrell and Jonas Björn Ohlsson on February 25, 2003 and is headquartered in Lund, Sweden. | Semiconductors | Chairman Director/Board Member | |
STRAWTEC Group AG
 STRAWTEC Group AG Engineering & ConstructionIndustrial Services STRAWTEC Group AG provides engineering and construction services. The firm offers installation, finishing and housing services. The company is headquartered in Heidelberg, Germany. | Engineering & Construction | Corporate Officer/Principal Chairman | |
| DNAPRINT GENOMICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| DEUTSCHE BALATON AG | Investment Banks/Brokers | Corporate Officer/Principal Chairman | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Delphi Unternehmensberatung AG
 Delphi Unternehmensberatung AG Financial ConglomeratesFinance Delphi Unternehmensberatung AG provides investment services. The private company is based in Heidelberg, Germany. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal | |
| Suffolk University | College/University | Masters Business Admin Masters Business Admin | |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Swyx Solutions GmbH
 Swyx Solutions GmbH Packaged SoftwareTechnology Services Swyx Solutions GmbH develops and provides software based internet protocol telephony solutions. Its products include unified communications and case studies, third party products and SIP-provider. The firm also offers communication software, phones, protocol and update services. The company was founded by Wolfgang Schröder, Ralf Ebbinghaus, Uwe Sauerbrey and Frank Heidemann in 1999 and is headquartered in Dortmund, Germany. | Packaged Software | Director/Board Member Chairman | |
Cavendish Kinetics, Inc.
 Cavendish Kinetics, Inc. SemiconductorsElectronic Technology Cavendish Kinetics, Inc. provides radio frequency tuning solutions for mobile devices in the wireless industry. It is a fabless supplier of tunable components for RF circuits used in cellular handsets, laptops, netbooks, tablets, and other consumer wireless devices. The firm offers tunable RF circuits, based on third-generation RF MEMS technology and its semiconductor processes, let users pack more performance into the same space. The company was founded by Charles Gordon Smith and Hermann M. Hauser in 1994 and is headquartered in San Jose, CA. | Semiconductors | Director/Board Member Director/Board Member | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Chairman | |
agnion Energy, Inc.
 agnion Energy, Inc. Alternative Power GenerationUtilities agnion Energy, Inc. supplies local bio-energy plants and specializes in transforming solid biomass into electricity and heat. The firm utilizes its patented Heatpipe-Reformer technology, which enables wood-based biomass to be converted into synthetic gas. Its decentralized plants can both produce synthetic natural gas (SNG) and hydrogen as well as support heat and power cogeneration. The company was founded in 2007 and is headquartered in Wilmington, DE. | Alternative Power Generation | Director/Board Member Director/Board Member | |
coramaze technologies GmbH
 coramaze technologies GmbH Medical SpecialtiesHealth Technology coramaze technologies GmbH operates as a medical device company which develops valve repair system. It offers mitramaze a novel concept for transcatheter mitral valve repair intended for treatment of inoperable patients suffering from severe functional mitral regurgitation. The company was founded by Laura Figulla and Till Neumann in 2013 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member | |
| SYMETIS SA | Biotechnology | Director/Board Member | |
| Zentralinstitut für Seelische Gesundheit | Director/Board Member | ||
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Biotechnology | Director/Board Member | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Unternehmertum Venture Capital Partners GmbH
 Unternehmertum Venture Capital Partners GmbH Investment ManagersFinance Unternehmertum Venture Capital Partners GmbH (UVC Partners) is a venture capital subsidiary of UnternehmerTUM GmbH, founded in 2011. The firm is headquartered in Munich, Germany, with an additional office in Berlin. | Investment Managers | Private Equity Investor | |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The private company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Pharmaceuticals: Major | Founder |
Statistiques
Internationale
| Allemagne | 25 |
| Etats-Unis | 11 |
| France | 6 |
| Suisse | 6 |
| Royaume-Uni | 3 |
Sectorielle
| Health Technology | 19 |
| Consumer Services | 12 |
| Finance | 9 |
| Electronic Technology | 5 |
| Technology Services | 4 |
Opérationnelle
| Director/Board Member | 358 |
| Chairman | 91 |
| Corporate Officer/Principal | 90 |
| Chief Executive Officer | 61 |
| Private Equity Investor | 60 |
Relations les plus connectées
| Insiders | |
|---|---|
| Hansjörg Plaggemars | 44 |
| Eric Archambeau | 43 |
| Bo Jesper Hansen | 34 |
| Regina Hodits | 33 |
| Russell Greig | 31 |
| Helmut Schühsler | 28 |
| Albert Joseph Markus | 22 |
| Chandra Paul Leo | 22 |
| Aniruddha Nazre | 21 |
| Stuart Essig | 21 |
| Heikki Lanckriet | 17 |
| Karl Nägler | 16 |
| Markus Hosang | 15 |
| Erich Schlick | 15 |
| Frank Böhnke | 15 |
- Bourse
- Insiders
- Ulrich Granzer
- Connexions Sociétés
